Mitochondrial immobilization mediated by syntaphilin facilitates survival of demyelinated axons

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 27, 2014, Pages 9953-9958

  Ohno, Nobuhiko ^a,c   Chiang, Hao ^a,d   Mahad, Don J ^a,e   Kidd, Grahame J ^a   Liu, LiPing ^a   Ransohoff, Richard M ^a   Sheng, Zu Hang ^b   Komuro, Hitoshi ^a   Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c UNIVERSITY OF YAMANASHI   (Japan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CUPRIZONE; FLECAINIDE; RAPAMYCIN; SODIUM;

ANIMAL CELL; ARTICLE; CELL SHAPE; CELL SURVIVAL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMYELINATING DISEASE; ELECTRIC ACTIVITY; IMMOBILIZED CELL; IN VITRO STUDY; MICROTUBULE; MITOCHONDRIAL VOLUME; MITOCHONDRION; MOUSE; NERVE FIBER; NERVE FIBER DEGENERATION; NONHUMAN; PRIORITY JOURNAL; TIME LAPSE IMAGING;

AXONS; FEMALE; HUMANS; MITOCHONDRIA; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE TISSUE PROTEINS; TIME-LAPSE IMAGING; VESICULAR TRANSPORT PROTEINS;

EID: 84903957220     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401155111     Document Type: Article

References (51)

1. Trapp BD, Nave KA (2008) Multiple sclerosis: An immune or neurodegenerative disorder? Annu Rev Neurosci 31:247-269.
2. Trapp BD, et al. (1998) Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338(5):278-285. (Pubitemid 28065253)
3. Ferguson B, Matyszak MK, Esiri MM, Perry VH (1997) Axonal damage in acute multiple sclerosis lesions. Brain 120(Pt 3):393-399. (Pubitemid 27153632)
4. Bitsch A, Schuchardt J, Bunkowski S, Kuhlmann T, Brück W (2000) Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain 123(pt 6):1174-1183. (Pubitemid 30312109)
5. Lassmann H, Brück W, Lucchinetti CF (2007) The immunopathology of multiple sclerosis: An overview. Brain Pathol 17(2):210-218. (Pubitemid 46466140)
6. Nave KA, Trapp BD (2008) Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 31:535-561.
7. Nave KA (2010) Myelination and support of axonal integrity by glia. Nature 468(7321):244-252.
8. Griffiths I, et al. (1998) Current concepts of PLP and its role in the nervous system. Microsc Res Tech 41(5):344-358. (Pubitemid 28308899)
9. Lappe-Siefke C, et al. (2003) Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat Genet 33(3):366-374. (Pubitemid 36278853)
10. Yin X, et al. (2006) Evolution of a neuroprotective function of central nervous system myelin. J Cell Biol 172(3):469-478.
11. Coleman M (2005) Axon degeneration mechanisms: Commonality amid diversity. Nat Rev Neurosci 6(11):889-898.
12. Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8(3):280-291.
13. Dutta R, et al. (2006) Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59(3):478-489. (Pubitemid 43358068)
14. Mahad DJ, et al. (2009) Mitochondrial changes within axons in multiple sclerosis. Brain 132(Pt 5):1161-1174.
15. Campbell GR, et al. (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69(3):481-492.
16. Misgeld T, Kerschensteiner M, Bareyre FM, Burgess RW, Lichtman JW (2007) Imaging axonal transport of mitochondria in vivo. Nat Methods 4(7):559-561. (Pubitemid 47214773)
17. Kiryu-Seo S, Ohno N, Kidd GJ, Komuro H, Trapp BD (2010) Demyelination increases axonal stationary mitochondrial size and the speed of axonal mitochondrial transport. J Neurosci 30(19):6658-6666.
18. Ohno N, et al. (2011) Myelination and axonal electrical activity modulate the distribution and motility of mitochondria at CNS nodes of Ranvier. J Neurosci 31(20):7249-7258.
19. Saxton WM, Hollenbeck PJ (2012) The axonal transport of mitochondria. J Cell Sci 125(Pt 9):2095-2104.
20. Schwarz TL (2013) Mitochondrial trafficking in neurons. Cold Spring Harb Perspect Biol 5(6).
21. Chang DT, Reynolds IJ (2006) Mitochondrial trafficking and morphology in healthy and injured neurons. Prog Neurobiol 80(5):241-268. (Pubitemid 46028946)
22. Berman SB, et al. (2009) Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol 184(5):707-719.
23. Sheng ZH, Cai Q (2012) Mitochondrial transport in neurons: Impact on synaptic homeostasis and neurodegeneration. Nat Rev Neurosci 13(2):77-93.
24. Kang JS, et al. (2008) Docking of axonal mitochondria by syntaphilin controls their mobility and affects short-term facilitation. Cell 132(1):137-148.
25. Misko AL, Sasaki Y, Tuck E, Milbrandt J, Baloh RH (2012) Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration. J Neurosci 32(12):4145-4155.
26. Evangelou N, et al. (2000) Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 123(pt 9):1845-1849. (Pubitemid 30664287)
27. Matsushima GK, Morell P (2001) The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11(1):107-116.
28. Narayanan SP, Flores AI, Wang F, Macklin WB (2009) Akt signals through the mammalian target of rapamycin pathway to regulate CNS myelination. J Neurosci 29(21):6860-6870.
29. Suzuki K (1969) Giant hepatic mitochondria: Production in mice fed with cuprizone. Science 163(3862):81-82.
30. Flatmark T, Kryvi H, Tangerås A (1980) Induction of megamitochondria by cuprizone (biscyclohexanone oxaldihydrazone). Evidence for an inhibition of the mitochondrial division process. Eur J Cell Biol 23(1):141-148. (Pubitemid 11162694)
31. Blakemore WF (1973) Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 20(1):63-72.
32. Ludwin SK (1978) Central nervous system demyelination and remyelination in the mouse: An ultrastructural study of cuprizone toxicity. Lab Invest 39(6):597-612.
33. Tsai J, Grutzendler J, Duff K, Gan WB (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7(11):1181-1183. (Pubitemid 39426234)
34. Nikić I, et al. (2011) A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med 17(4):495-499.
35. Bjartmar C, Trapp BD (2001) Axonal and neuronal degeneration in multiple sclerosis: Mechanisms and functional consequences. Curr Opin Neurol 14(3):271-278. (Pubitemid 32510589)
36. Stys PK, Waxman SG, Ransom BR (1992) Ionic mechanisms of anoxic injury in mammalian CNS white matter: Role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci 12(2):430-439.
37. Kapoor R, Davies M, Blaker PA, Hall SM, Smith KJ (2003) Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration. Ann Neurol 53(2):174-180. (Pubitemid 36163998)
38. Bechtold DA, et al. (2005) Axonal protection in experimental autoimmune neuritis by the sodium channel blocking agent flecainide. Brain 128(pt 1):18-28. (Pubitemid 40070516)
39. Skripuletz T, Gudi V, Hackstette D, Stangel M (2011) De- and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the unexpected. Histol Histopathol 26(12):1585-1597.
40. Mutsaers SE, Carroll WM (1998) Focal accumulation of intra-axonal mitochondria in demyelination of the cat optic nerve. Acta Neuropathol 96(2):139-143. (Pubitemid 28356526)
41. Sathornsumetee S, McGavern DB, Ure DR, Rodriguez M (2000) Quantitative ultrastructural analysis of a single spinal cord demyelinated lesion predicts total lesion load, axonal loss, and neurological dysfunction in a murine model of multiple sclerosis. Am J Pathol 157(4):1365-1376.
42. Witte ME, et al. (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219(2):193-204.
43. Waxman SG (2006) Axonal conduction and injury in multiple sclerosis: The role of sodium channels. Nat Rev Neurosci 7(12):932-941.
44. Fünfschilling U, et al. (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485(7399):517-521.
45. Lee Y, et al. (2012) Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487(7408):443-448.
46. Persson AK, et al. (2013) Sodium channels contribute to degeneration of dorsal root ganglion neurites induced by mitochondrial dysfunction in an in vitro model of axonal injury. J Neurosci 33(49):19250-19261.
47. Lo AC, Saab CY, Black JA, Waxman SG (2003) Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J Neurophysiol 90(5):3566-3571. (Pubitemid 37430046)
48. Bechtold DA, Kapoor R, Smith KJ (2004) Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol 55(5):607-616. (Pubitemid 38544320)
49. Stys PK (2005) General mechanisms of axonal damage and its prevention. J Neurol Sci 233(1-2):3-13.
50. Cardona A, et al. (2012) TrakEM2 software for neural circuit reconstruction. PLoS ONE 7(6):e38011.
51. Birgbauer E, Rao TS, Webb M (2004) Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res 78(2):157-166. (Pubitemid 39313787)